| Structure | Chemical Name | CAS | MF |
|
ent-Pazufloxacin-d4 Mesylate
|
|
C17H19FN2O7S
|
|
ent-Pazufloxacin Mesylate
|
677004-96-5
|
C17H19FN2O7S
|
|
ent-Paroxol
|
389573-45-9
|
C13H18FNO
|
|
Entomophthora exitialis
|
67891-99-0
|
|
|
Entonox
|
54510-89-3
|
N2O3
|
|
ent-PGE2
|
65085-69-0
|
C20H32O5
|
|
ent-PGF2α
|
54483-31-7
|
C20H34O5
|
|
ent-OseltaMivir Phosphate
|
1035895-89-6
|
C16H29N2O8P
|
|
|
EPAESTERSOFPLANTSTEROLS
|
|
|
|
ENT-PIMARA-8(14),15-DIEN-19-OIC ACID
|
|
C20H30O2
|
|
|
EPA 552.2 Esters Calibration Mix (without Dalapon)
|
|
|
|
ent-3-Oxokauran-17-oic acid
|
151561-88-5
|
C20H30O3
|
|
|
EPA 525 Fortification Solution A
|
|
|
|
|
EPA 524.2 Fortification Solution
|
|
|
|
|
EPA 525 Fortification Solution B
|
|
|
|
ENTOZONDIHYDROCHLORIDE
|
73972-50-6
|
C22H29ClN4O5
|
|
|
ent-Prostaglandin F2α AChE Tracer
|
|
|
|
|
ent-Prostaglandin F2α EIA Kit
|
|
|
|
|
ent-Prostaglandin F2α EIA Antiserum
|
|
|
|
|
ent-Prostaglandin F2α EIA Standard
|
|
|
|
|
ent1 protein
|
|
|
|
|
ent2 protein
|
|
|
|
|
EPA 552 Halogenated Acetic Acids Mix
|
|
|
|
|
EPA Haloethers Mix
|
|
|
|
|
EPA 552.2 Haloacetic Acids Mix
|
|
|
|
|
ENTRADIOL USP
|
|
|
|
|
EPA HC Purgeable C
|
|
|
|
|
EPA HC Purgeable B
|
|
|
|
|
ent-[retro-AMyloid b-Protein (16-20)]-b-Ala-D-Lys(ent-[AMyloid b-Protein (16-20)]), (ffvlk)2(bA)k (tandeM diMer)
|
|
|
|
|
EPA 508.1 Herbicides Mix
|
|
|
|
|
EPA GRO Mix
|
|
|
|
(E)-N-(2-Trifluoromethylphenyl)indan-1-imine
|
|
C16H12F3N
|
|
(2E)-6,6,N-Trimethyl-N-(1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H23NS
|
|
(2E)-6,6,N-Trimethyl-N-(7-chloro-1-benzothiophen-3-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(2E)-6,6,N-Trimethyl-N-(3-bromo-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22BrNS
|
|
(2E)-6,6,N-Trimethyl-N-(3-methylthio-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C20H25NS2
|
|
(2E)-6,6,N-Trimethyl-N-(2-chloro-1-benzothiophen-4-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(2E)-6,6,N-Trimethyl-N-(5-chloro-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(3E)-N-(2-Trifluoromethylphenyl)-4-phenyl-3-buten-2-imine
|
|
C17H14F3N
|
|
(2E)-6,6,N-Trimethyl-N-(2-chloro-1-benzothiophen-3-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(2E)-6,6,N-Trimethyl-N-(3-fluoro-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22FNS
|
|
(2E)-6,6,N-Trimethyl-N-(1-benzothiophen-4-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H23NS
|
|
(E)-N-(2-Trifluoromethylphenyl)tetralin-1-imine
|
|
C17H14F3N
|
|
(2E)-6,6,N-Trimethyl-N-(3-trifluoromethyl-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C20H22F3NS
|
|
(2E)-6,6,N-Trimethyl-N-(1-benzothiophen-3-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H23NS
|
|
(2E)-N-[5-(TRIFLUOROMETHYL)-1,3,4-THIADIAZOL-2-YL]-3-(3,4,5-TRIMETHOXYPHENYL)ACRYLAMIDE
|
|
C15H14F3N3O4S
|
|
5-[E-2-[N-[6-(TRIFLUOROACETAMIDO)HEXYL]CARBOXAMIDO]VINYL]-5'- O-(4,4'-DIMETHOXYTRITYL)-2'-DEOXYURIDINE, 3'-[(2-CYANOETHYL)-(N,N-DIISOPROPYL)]PHOSPHORAMIDITE
|
210534-16-0
|
C50H62F3N6O10P
|
|
(2E)-6,6,N-Trimethyl-N-(2-chloro-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(2E)-6,6,N-Trimethyl-N-(2-fluoro-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22FNS
|
|
(E)-N-(Trimethylsilyl)benzenemethanimine
|
|
C10H15NSi
|
|
(2E)-6,6,N-Trimethyl-N-(3-methyl-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C20H25NS
|
|
(2E)-6,6,N-Trimethyl-N-(3-chloro-1-benzothiophen-4-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(2E)-6,6,N-Trimethyl-N-(4-chloro-1-benzothiophen-7-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
(2E)-6,6,N-Trimethyl-N-(5-chloro-1-benzothiophen-3-ylmethyl)-2-hepten-4-yn-1-amine
|
|
C19H22ClNS
|
|
|
ent-Sarkomycin
|
|
|
|
|
ent-(16S)-Atisan-13,17-oxide
|
|
C20H32O
|
|
ent S-(+)-Atomoxetine Hydrochloride
|
82857-39-4
|
C17H22ClNO
|
|
Ent-16S,17-dihydroxyatisan-3-one
|
112523-91-8
|
C20H32O3
|
|
ent-Rosuvastatin SodiuM Salt
|
|
C22H27FN3NaO6S
|
|
ent-Rosuvastatin Lactone
|
615263-62-2
|
C22H26FN3O5S
|
|
ent-Rosuvastatin tert-Butyl Ester
|
615263-60-0
|
C26H36FN3O6S
|
|
ent-Rosuvastatin Acyl-β-D-glucuronide
|
|
C28H36FN3O12S
|
|
|
EPA II PEROXIDASE PROTECTION BUFFER
|
|
|
|
ent-Tadalafil-d3
|
|
C22H18N3O4
|
|
ent-Tadalafil
|
629652-72-8
|
C22H19N3O4
|
|
|
Epaindrosterone
|
|
|
|
|
EPA 524 Internal Standard Mix
|
|
|
|
|
EPA 508.1 Instrument Check Mix
|
|
|
|
|
EPA 525,525.1 Internal Standard Mix
|
|
|
|
|
EPA 502 Internal Standard Mix
|
|
|
|
ent-3β-Tigloyloxykaur-16-en-19-oic acid
|
79406-09-0
|
C25H36O4
|
|
|
ENVACAR
|
|
|
|
|
ent-Trachyloban-19-oic acid
|
|
|
|
|
EnvA protein
|
|
|
|
ent-Voriconazole
|
137234-63-0
|
C16H14F3N5O
|
|
|
EPA Method 524.3
|
|
|
|
|
EPA Method 524.3 Internal Standard
|
|
|
|
|
EPA Method 524.3 Surrogate Standard
|
|
|
|
|
EPA Method 524.3 Internal/Surrogate Std.
|
|
|
|
|
EPA Method 535 Metabolites - Solutions
|
|
|
|
|
EPA Method 532 Phenylurea Pesticides Mixture
|
|
|
|
|
EPA Method 535 Metabolites - Neat
|
|
|
|
|
EPA Method 504.1 Mixture
|
|
|
|
|
EPA Method 200.7 Mixed Calibration Standard II
|
|
|
|
|
EPA Method 200.7 Mixed Calibration Standard V
|
|
|
|
|
EPA Method 200.7 Spiking Standard 5
|
|
|
|
|
EPA Method 200.8 & ICP-MS Tuning Standard
|
|
|
|
|
EPA Method 200.7 Tuning Solution
|
|
|
|
|
EPA Method 200.7 Calibration Kit
|
|
|
|
|
EPA Method 200.7 Interference Check Std 1
|
|
|
|
|
EPA Method 200.7 Mixed Calibration Standard III
|
|
|
|
|
EPA Method 200.7 Calibration Standard 4
|
|
|
|
|
EPA Method 200.7 Mixed Calibration Standard IV
|
|
|
|
|
EPA Method 624 Kit
|
|
|
|
|
EPA Method 200.7 Calibration Standard 1B
|
|
|
|
|
EPA Method 200.7 SIC Solution III
|
|
|
|
|
EPA Method 200.7 Calibration Standard 3
|
|
|
|
|
EPA Method 200.7 SIC Solution II
|
|
|
|
|
EPA Method 200.7 LPC Solution
|
|
|
|
|
EPA Method 200.7 Spiking Standard 2
|
|
|